1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Data-to-Model: An Academic-Industrial Partnership (D2M-AIP) (UG3/UH3) is sponsored by National Cancer Institute (NCI). This funding opportunity supports academic-industrial partnerships to integrate AI with imaging and multimodal data for precision medicine in cancer research, with potential applications in cancer prevention, early detection, and screening.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Extramural researchers are encouraged to check out NCI funding opportunities and resources. Confirm the full requirements in the official notice before applying.
Applications for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Data-to-Model: An Academic-Industrial Partnership (D2M-AIP) (UG3/UH3) are due October 19, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Data-to-Model: An Academic-Industrial Partnership (D2M-AIP) (UG3/UH3) is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed) is sponsored by National Institutes of Health (NIH). NIH funds a Logistics Center to coordinate the PRIMED-AI program, which develops AI-based clinical decision support tools integrating medical imaging with multimodal health data. This center will manage administration, evaluation, and outreach for a consortium developing these AI tools.
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed) is sponsored by National Institutes of Health (NIH) - Common Fund. The Validation Center will serve as a hub for validating AI-enabled, multimodal CDS tools, supporting reproducibility, interoperability, and clinical translation in precision medicine.
On May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article